Zhu D, Ma J, Wang W, Shi B, et al. Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial. Diabetologia 2025 Nov 21. doi: 10.1007/s00125-025-06593.
PMID: 41272211